Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users

About 5% of women use illicit substances during pregnancy, and approximately 22% of these also report using tobacco or alcohol. While a number of treatment programs have begun to offer treatment specifically designed for pregnant substance abusers, it is difficult to keep these women in treatment. Brief motivational sessions have been found to improve treatment engagement and outcomes in both alcohol- and drug-using women. This study compared one such treatment intervention, Motivational Enhancement Therapy (MET), with standard treatment. The three individual MET sessions focused on developing rapport, exploring perceived pros and cons of using substances, reviewing the participant's feedback on the consequences of substance use and the status of her pregnancy, and developing a change plan or strengthening the commitment to change. Patients assigned to standard treatment received an equal number of visits consisting of the treatment normally given in that clinic.

CTN Protocol ID: 
CTN-0013
DSMB ID: 
DSMB-0013
Status: 
Completed
ClinicalTrials.gov ID: 

Principal Investigator(s)

T. John Winhusen, Ph.D.

Professor of Psychiatry and Behavioral Neuroscience, Director of Addiction Sciences Division
University of Cincinnati
Addiction Sciences Division

3131 Harvey Avenue, Suite 104
Cincinnati, OH 45229-3006
United States

Participating Sites